Depression Flashcards

1
Q

Describe depression.

A
  • Episodes can be mild, moderate or severe.
  • 8-12% of UK population affected each year.
  • 121m people worldwide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the Monamine Theory and evidence for it.

A
  • Decreased serotonin in depression.
  • Common excitatory neurotransmitter: releases a lot of Dopamine
  • Anti-depressants target serotonin
  • Tryptophan diets = lower mood: effect Cinglulate 25 area of brain: ‘Sadness’ area. Tryptophan is a precursor to serotonin.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the most common treatment for depression and how does it work?

A
  • SSRI’s.
  • block reuptake of serotonin and noradrenaline
  • Short-term: transport anti-depressants back to pre-synapse. Long-term: reduction in number of receptors available, more serotonin in synaptic cleft left.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the success rates of treatment?

A
  • 33% finish treatment after 14 weeks of citalopram

- 47% shown greater than 50% reduction in baseline symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 4 secondary types of treatment?

A
  1. CBT
  2. Electroconvulsive therapy
  3. TMS
  4. DBS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the percentage genetic risk of depression?

A

40-50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What brain changes increase the risk of depression?

A
  • Stroke to the left side
  • Lesion in PFC
  • Lesion/disorder affecting the basal ganglia (e.g. Parkinsons)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is not constant in neural correlates of depression?

A

Structural effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What does Clark et al. (2009) state about neural correlates of depression?

A
  • Frontal lobes and basal ganglia are important areas
  • Dysregulation of medial/orbitofrontal circuit
  • Amygdala dysregular in mood disorders
  • Decreased volume in the ACC
  • Functional hyperactivity in the subgenal cingulate
  • 41% decrease in serotonin binding potential
  • 27% decrease in medial temporal lobe (amygdala and hippocampus
  • Serotonin used to modulate emotional behaviour and causes cognitive dysfunction possibly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why is Brodmann area 25 important?

A
  • Seems to be linked to serotonin and ‘sad’ area of the brain.
  • Depressed patients have no activation in this area when hearing sad stories, but activation normalises after treatment (SSRIs for 6 weeks - Mayberg et al., 2006)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What did Liotti et al. (2002) find about cerebral blood flow?

A

No difference in activation between healthy and depressed when measuring cerebral blood flow with PET.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How effective has DBS been?

A

4/6 patients responded well, but no control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Where does DBS have no effect on depression?

A

Nucleus Accumbens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What did Wagner et al. (2006) find?

A
  • Depression leads to cortical inefficiency

- On a Stroop task, depressed patients performed as well but needed more frontal activation to do so

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the estimated effect of depression on memory?

A

2-3% reduction in paragraph recall with every depressive episode

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What brain region is smaller in depression and why?

What controversy has this caused?

A
  • Hippocampus
  • Higher levels of cortisol seen in depression: cortisol is toxic to the hippocampus and causes it to shrink
  • Unknown if this is a side-effect of depression or a cause
17
Q

How can the effects of shrinkage be prevented in depression?

A
  • Anti-depressants help protect hippocampus

- Duration of untreated depression is negatively correlated with volume of the hippocampus

18
Q

What has been found about Affective Processing in depression?

A
  • Biased to more negative aspects of the environment
  • More likely to recall negative memories
  • Depressed patients are impaired at recognising happy faces
  • Go/nogo task: depressed faster responses to sad faces
  • Greater frontal activation for negative words: more effort to suppress negative than controls
19
Q

Define executive control.

A

Executive control is the ability to focus on the aspect of the environment and suppress the rest during a task: frontal cortex implicated in ability.

20
Q

What has been found about Executive Control in depression?

A
  • Depressed patients are worse at Stroop tasks: required to read word and suppress colour.
  • indicates cortical inefficiency in executive tasks: takes more effort to perform at the same level
  • Dysregulation of dorsal and lateral PFC during EF tasks
21
Q

What has been found about Memory in depression?

A
  • Hippocampal pathology suggests a memory deficit
  • Depressed patients have issues with recall compared to controls
  • Longer duration of illness = worse memory
22
Q

What causes the missing reappraisal of emotions in depression?

A

Increased connectivity of amygdala and VLPFC (is missing)

23
Q

What has been found about feedback sensitivity in depression?

A
  • Ruminate over failures and criticism
  • Exaggerated response to negative feedback in labs
  • More likely to fail again if failed once
  • Depression does not decrease amygdala activity after negative feedback like healthy
  • Altered positive valence processing
24
Q

What are the neural correlates associated with affective processing?

A
  • Hyperactivity in the amygdala = negative responses
  • Serotonin regulates affective processing: decreased in depression therefore irregular affective processing
  • Cg25 has a role in affective bias and implicated in depression
  • Greater frontal activation for negative words